Gerald A. Steiner - 18 Feb 2026 Form 4 Insider Report for ALBEMARLE CORP (ALB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Feb 2026, 16:15:35 UTC
Prior SEC filing
03 Jul 2025
Next SEC filing
06 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ander C. Krupa, Attorney-in-Fact

Key filing fact

Gerald A. Steiner filed Form 4 for ALBEMARLE CORP (ALB) on 20 Feb 2026.

Key facts

  • This page summarizes Gerald A. Steiner's Form 4 filing for ALBEMARLE CORP (ALB).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Feb 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 03 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001143210 Primary reporting owner

STEINER GERALD A

Relationship
Director
Address
ALBEMARLE CORPORATION, 4250 CONGRESS STREET, SUITE 900, CHARLOTTE
Signature
/s/ Ander C. Krupa, Attorney-in-Fact
Signature date
20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+153
Change %
+1.4%
Price
$0.000000
Shares after
11,165
Date
18 Feb 2026
Ownership
Direct
Footnotes
F1, F2
ALB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+781
Change %
+7%
Price
$0.000000
Shares after
11,946
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALB transaction Derivative

Phantom Stock

Options Exercise

Transaction value
Shares
-153
Change %
-1.4%
Price
Shares after
10,408
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
153
Exercise price
Footnotes
F2, F4, F5, F6, F7
ALB transaction Derivative

Phantom Stock

Options Exercise

Transaction value
Shares
-781
Change %
-7.5%
Price
Shares after
9,627
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
781
Exercise price
Footnotes
F2, F6, F7, F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

The reporting person settled 153 shares of Phantom Stock for the same number of shares of common stock.

Footnote F2

Phantom Stock units convert 1 for 1 into common stock.

Footnote F3

The reporting person settled 781 shares of Phantom Stock for the same number of shares of common stock.

Footnote F4

Represents deferred director compensation under the Albemarle Corporation 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors.

Footnote F5

Exerciseable in five annual installments beginning on February 15th of the year after the year in which the reporting person reached 65 years of age.

Footnote F6

No expiration date.

Footnote F7

Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account.

Footnote F8

Represents deferred director compensation under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors

Footnote F9

Exercisable in a single lump sum on February 15th of the calendar year after the year in which the reporting reached 65 years of age.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .